ES2186006T3 - Derivados de la 1-acrilolindolina y su utilizacion como profarmacos de agentes anticancerigenos. - Google Patents

Derivados de la 1-acrilolindolina y su utilizacion como profarmacos de agentes anticancerigenos.

Info

Publication number
ES2186006T3
ES2186006T3 ES97948036T ES97948036T ES2186006T3 ES 2186006 T3 ES2186006 T3 ES 2186006T3 ES 97948036 T ES97948036 T ES 97948036T ES 97948036 T ES97948036 T ES 97948036T ES 2186006 T3 ES2186006 T3 ES 2186006T3
Authority
ES
Spain
Prior art keywords
profarmacos
anticancerigenos
acrilolindolina
derivatives
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97948036T
Other languages
English (en)
Inventor
William Alexander Denny
Moana Tercel
Graham John Atwell
Jared Milbank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Application granted granted Critical
Publication of ES2186006T3 publication Critical patent/ES2186006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS ANALOGOS AMINO DE LA CLASE GENERAL DE LOS CICLOPROPILINDOLES Y SUS PRECURSORES SECOS, Y SE OCUPA PARTICULARMENTE DEL USO DE ESTOS COMPUESTOS COMO PRO -MEDICAMENTOS PARA LA TERAPIA CON PRODROGAS ENZIMATICAS DIRIGIDAS A ANTICUERPOS (ADEPT) Y TERAPIA CON PRO - FARMACOS DIRIGIDOS A LOS GENES (GDEPT) PARA EL CANCER.
ES97948036T 1996-12-13 1997-12-12 Derivados de la 1-acrilolindolina y su utilizacion como profarmacos de agentes anticancerigenos. Expired - Lifetime ES2186006T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9625913.0A GB9625913D0 (en) 1996-12-13 1996-12-13 Novel cyclopropylindoles and their seco precursors,and their use as prodrugs

Publications (1)

Publication Number Publication Date
ES2186006T3 true ES2186006T3 (es) 2003-05-01

Family

ID=10804392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97948036T Expired - Lifetime ES2186006T3 (es) 1996-12-13 1997-12-12 Derivados de la 1-acrilolindolina y su utilizacion como profarmacos de agentes anticancerigenos.

Country Status (12)

Country Link
EP (1) EP0944596B1 (es)
JP (1) JP2001506623A (es)
AT (1) ATE226194T1 (es)
AU (1) AU728053B2 (es)
CA (1) CA2272952A1 (es)
DE (1) DE69716463T2 (es)
DK (1) DK0944596T3 (es)
ES (1) ES2186006T3 (es)
GB (1) GB9625913D0 (es)
NZ (1) NZ335841A (es)
PT (1) PT944596E (es)
WO (1) WO1998025898A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909612D0 (en) * 1999-04-26 1999-06-23 Cancer Res Campaign Tech N-protected amines and their use as prodrugs
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
AU2009320481C1 (en) 2008-11-03 2016-12-08 Syntarga B.V. Novel CC-1065 analogs and their conjugates
EP2491030B1 (en) * 2009-10-22 2015-07-15 Fibrotech Therapeutics PTY LTD Fused ring analogues of anti-fibrotic agents
AU2011243294C1 (en) 2010-04-21 2015-12-03 Syntarga B.V. Novel conjugates of CC-1065 analogs and bifunctional linkers
AU2015205574B2 (en) 2014-01-10 2019-08-15 Byondis B.V. Method for purifying Cys-linked antibody-drug conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8705477D0 (en) * 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US5214065A (en) * 1990-06-11 1993-05-25 Kyowa Hakko Kogyo Co., Ltd. Dc-89 derivatives
EP0520435A3 (en) * 1991-06-28 1993-05-05 Kyowa Hakko Kogyo Co., Ltd. Dc-89 derivatives

Also Published As

Publication number Publication date
AU728053B2 (en) 2001-01-04
NZ335841A (en) 2000-08-25
WO1998025898A1 (en) 1998-06-18
DE69716463D1 (de) 2002-11-21
EP0944596A1 (en) 1999-09-29
PT944596E (pt) 2003-03-31
DK0944596T3 (da) 2002-12-16
JP2001506623A (ja) 2001-05-22
CA2272952A1 (en) 1998-06-18
ATE226194T1 (de) 2002-11-15
AU5419298A (en) 1998-07-03
DE69716463T2 (de) 2003-06-05
EP0944596B1 (en) 2002-10-16
GB9625913D0 (en) 1997-01-29

Similar Documents

Publication Publication Date Title
BG104247A (bg) Производни на резорцинола
SV1996000033A (es) Isotiazolonas
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
PT797439E (pt) Utilizacao de pramipexote como agente neuroprotector
PT799318E (pt) Metodos para modificar porcoes hidrato de carbono
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
ES2119762T3 (es) Tratamiento de la catarata con la ayuda de derivados 15-ceto-prostaglandinas.
ES2181766T3 (es) Analogos de delda 12,13-isotaxol, uso antineoplasico y composiciones farmaceuticas que los contienen.
BR9910908A (pt) Indenopirrolocarbazóis ligados em ponte
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
YU401A (sh) Sredstva sa antidepresivnim dejstvom
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
PT1028950E (pt) Quinazolina-2,4-dionas 7-substituidas uteis como agentes antibacterianos
ES2189993T3 (es) Sulfamidas de aminoacilo para el tratamiento de trastornos hiperproliferativos.
DK1040119T3 (da) Hemiasterlinanaloger
MXPA94001345A (es) Derivados de poliamina como agentes radioprotectores.
ES2186006T3 (es) Derivados de la 1-acrilolindolina y su utilizacion como profarmacos de agentes anticancerigenos.
SE9801494D0 (sv) Novel use
ES2189182T3 (es) Empleo de alcoholes como aditivos para revoques y/o morteros.
EP0423747A3 (en) Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates
SE9604582D0 (sv) Novel compounds
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
SE9602416D0 (sv) New forms of an organic salt of N'N-diacetylcystine